Clinical Study
Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle
Table 3
Baseline NPI results.
| Subitems NPI | Number of patients/48 (%) | Frequency × severity | Caregiver distress |
| hallucinations | 20 (42%) | 2 | 1 | Delusions | 10 (21%) | 1 | 1 | Agitation/aggression | 5 (10%) | 2 | 1 | Dysphoria/depression | 22 (46%) | 4 | 2 | Anxiety | 26 (54%) | 6 | 2 | Irritability | 7 (15%) | 4 | 2 | Disinhibition | 2 (4%) | 2 | 2 | Euphoria | 3 (6%) | 2 | 2 | Apathy | 37 (77%) | 8 | 4 | Aberrant motor behavior | 3 (6%) | 2 | 2 | Sleep behavior change | 6 (12%) | 4 | 3 | Appetite change | 2 (4%) | 2 | 2 |
|
|